A5075225784- Economic and Financial Impacts of Cancer
- Chronic Lymphocytic Leukemia Research
- Pharmaceutical Economics and Policy
- Cancer Risks and Factors
- Emergency and Acute Care Studies
- Respiratory viral infections research
- Health Systems, Economic Evaluations, Quality of Life
- Global Cancer Incidence and Screening
- Healthcare Policy and Management
- Geriatric Care and Nursing Homes
- Frailty in Older Adults
- Chronic Myeloid Leukemia Treatments
- Health Literacy and Information Accessibility
- Palliative Care and End-of-Life Issues
- Ear Surgery and Otitis Media
- Mobile Health and mHealth Applications
- Telemedicine and Telehealth Implementation
- Acute Lymphoblastic Leukemia research
Case Western Reserve University
2021-2024
University School
2021-2024
Duke University
2017-2021
University Hospitals of Cleveland
2021
Medicare Advantage (MA) enrollment has increased over the past 2 decades. We compare receipt of standard treatment, time to treatment initiation (TTI), and overall survival (OS) between fee-for-service (FFS) MA for women in Ohio with breast cancer. Retrospective cohort. used cancer registry data linked files identify diagnosed 2011 2016 local- or regional-stage evaluated association FFS each outcome, adjusting age, race, marital status, county type, neighborhood poverty level, stage, hormone...
IntroductionDespite mounting consensus that end-of-life (EOL) care for patients with cancer should focus on improving quality of life, many continue to receive aggressive, disease-oriented treatment until death. Within this group, increased frailty may be at higher risk adverse treatment-related outcomes. We therefore examined the relationship between degree and receipt aggressive EOL among Medicare-insured in Ohio.Materials MethodsFrom Ohio Cancer Incidence Surveillance System (OCISS)...
Abstract Introduction: Relative to Medicare beneficiaries receiving care through the traditional fee-for-service system (FFS), percentage of Americans covered by Advantage (MA) plans has increased over last decade. As more patients enroll in MA plans, comparison outcomes between FFS and groups gained renewed importance. Ohio a high penetration but differences is under-studied. Breast cancer second most common type among women, therefore understanding nuances breast treatment broad...
97 Background: Insurance plans vary coverage for infusional (IV) vs oral drugs, leading some to suggest that patients on drugs pay more OOP than those IV drugs. 43 states have passed laws requiring insurers cover equivalently Yet, there is little evidence these “parity laws” are effective. Our aim was estimate impact of parity expenses Methods: We sought determine how quickly reach their plan’s annual maximum (max) as a surrogate expense. used 2017 data from Healthcare.gov public use files...
6620 Background: Insurance plans vary coverage for infusional (IV) vs oral drugs, leading some to suggest that patients on drugs pay more OOP than those IV drugs. 43 states have passed laws requiring insurers cover equivalently Yet, there is little evidence these “parity laws” are effective. Our aim was estimate impact of parity expenses Methods: We sought determine how quickly reach their plan’s annual maximum (max) as a surrogate expense. used 2017 data from Healthcare.gov public use files...